United States-based CVS Health (NYSE: CVS) is to provide COVID-19 vaccinations to long-term care facilities throughout the United States when a vaccine becomes available, it was reported on Friday.
CVS Health says that it has the experience and expertise to play a vital role in the COVID-19 vaccination effort. It quickly mobilised its colleagues and resources to provide COVID-19 testing sites in the country and have now administered over five million COVID tests.
Troyen Brennan, MD, chief medical officer, CVS Health, said, 'CVS Health has been on the front lines of the fight against COVID-19, working across the health care spectrum in all the communities we serve and that will continue to be the case when we have a vaccine to administer. Our nation's elderly living in long-term care facilities are one of the most vulnerable populations. With early access to a vaccination, we can help keep them, and the staff caring for them, healthy and safe.'
Avetra unveils site-centric CRO operating model
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Zoetis announces EU approval for Portela to relieve osteoarthritis pain in cats
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults